Alimera Sciences reported $-1937000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US $ -18137000 15.51M
Alimera Sciences ALIM:US $ -1937000 2.21M
Applied Genetic Technologies AGTC:US $ -18087000 4.61M
Bayer BAYN:GR 2.28B 1.89B
Insmed INSM:US $ -100938000 513K
Novartis NOVN:VX 3.32B 176M
Ophthotech OPHT:US $ -49753000 15.08M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M